Sue Siegel is a seasoned board director, former CEO, and venture capitalist across life sciences, healthcare, and technology. She currently serves on the boards of Align Technology, Illumina, and KFF (formerly Kaiser Family Foundation), and is Chairman of the Board of The Engine, built by Massachusetts Institute of Technology (“MIT”). Over her career, she has served on more than 20 public, private, and nonprofit boards including multiple chair roles. Her executive career includes serving as Chief Innovation Officer at General Electric (“GE”), CEO of GE Ventures & Licensing, and CEO of Healthymagination, advancing investments and partnerships at the intersection of healthcare and technology.

Previously, she was a General Partner at Mohr Davidow Ventures, leading life sciences and precision health investments, and President & Board Director of Affymetrix. She served in executive roles at Amersham, PLC, DuPont, Inc., and BioRad, Inc. In public service, Sue has served on President Obama’s Precision Medicine Initiative Working Group, catalyzing the All of Us research program; was a founding board member of the National Center for Advancing Translational Sciences; and acted as a White House Fellows selection judge under multiple administrations.

She also co-chairs Stanford Medicine’s Board of Fellows and serves on the Innovation Growth Board of Mass General Brigham. She is an Aspen Institute Henry Crown Fellow and serves on the faculty of MIT Sloan School of Management.